Active

AMPHIKTION

Switched

BE0803632924

Rechtspersoon Private limited company 1 establishment

Zavelput 17, 1000 Brussel Activiteiten van holdings

Active for

3 year, 2 months

Financials

Financial year 2024

Worth noting

  • More debts than assets in the latest financial year.
  • Little cash and receivables against the short-term debts.

Gross margin

€ 200,476

▲ 2381% vs 2023

Profit

Growing

€ 33,500

▲ 112% vs 2023

Debts

High

€ 1.8 million

▲ 5% vs 2023

AMPHIKTION from Brussel, company number BE0803632924, closed financial year 2024 with a result of € 33,500 after tax. For that financial year AMPHIKTION recorded a gross margin of € 200,476 and equity of € -196,258. Compared with financial year 2023, the result moved from € -269,758 to € 33,500. Profitable, and profit is growing. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on September 17, 2025.

What happened at AMPHIKTION?

What happened at AMPHIKTION in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2024: profit of € 33,500. filed late Source: NBB ↗
  • New establishment in Brussel. KBO
  • PHARMALEGAL BV became a director. NBB
  • Start of the company according to the CBE. KBO

In short

From € 269,758 loss in 2023 to € 33,500 profit in 2024.

Best year ever: 2024, with € 33,500 profit.

A new publication or filing at AMPHIKTION? We notify you, reason included.

Follow AMPHIKTION

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Behind AMPHIKTION is PHARMALEGAL BV. PHARMALEGAL BV is also behind ZORGPUNT, Lynxcare Clinical Informatics, ASYLIA DIAGNOSTICS, Curaevia and Thuiszorg Cooperatie.

See the full network in the app

Directors

According to the 2024 annual accounts

PHARMALEGAL BV

Director · represented by DE FEU GEORGES

Also active at: ZORGPUNT, Lynxcare Clinical Informatics, ASYLIA DIAGNOSTICS +3 more

since 2023

Establishments

Establishment units

Physical locations of this company

Registered office

Zavelput 17

1000 Brussel

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0803.632.924
VAT number
BE 0803.632.924
Registered office
Zavelput 17, 1000 Brussel
Names & denominations
AMPHIKTION
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
5 July 2023
Peppol
Active · Active since 16 Dec 2025
Activities · NACE

Activiteiten van holdings

Holdings

Handel in eigen onroerend goed

Frequently asked questions

What is the enterprise number of AMPHIKTION?
The enterprise number of AMPHIKTION is BE0803632924.
What is the address of AMPHIKTION?
The registered office of AMPHIKTION is located at Zavelput 17, 1000 Brussel.
When was AMPHIKTION founded?
AMPHIKTION was founded on 5 July 2023.
What is the main activity of AMPHIKTION?
The main activity of AMPHIKTION is "Activiteiten van holdings" (NACE code 64210).
Does AMPHIKTION have a website?
No website is currently known for AMPHIKTION.
How much profit did AMPHIKTION make in 2024?
AMPHIKTION posted a profit after taxes of € 33,500 in financial year 2024.
What is the revenue of AMPHIKTION?
As a small company, AMPHIKTION is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € 200,476.
Where can I find the annual accounts of AMPHIKTION?
AMPHIKTION files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of AMPHIKTION?
According to the 2024 annual accounts, the directors of AMPHIKTION are: PHARMALEGAL BV.
Who owns AMPHIKTION?
Behind AMPHIKTION is PHARMALEGAL BV. PHARMALEGAL BV is also behind ZORGPUNT, Lynxcare Clinical Informatics, ASYLIA DIAGNOSTICS, Curaevia and Thuiszorg Cooperatie.